Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?-Reference-Cited by-同舟云学术

Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout?

Published:2020-05-07 Issue:9 Volume:45 Page:2705-2716
ISSN:2366-004X
Container-title:Abdominal Radiology
language:en
Short-container-title:Abdom Radiol

Author:

Baek Kyoung A.,Kim Seung Soo^ORCID,Shin Hyeong Cheol,Hwang Jeong Ah,Choi Seo-Youn,Lee Woong Hee,Park Chan Ho,Lee Hyoung Nam,Heo Nam Hun

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://link.springer.com/content/pdf/10.1007/s00261-020-02553-z.pdf

Reference48 articles.

1. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53 (3):1020-1022

2. Mittal S, El-Serag HB (2013) Epidemiology of HCC: consider the population. Journal of clinical gastroenterology 47:S2

3. Kim TH, Kim SY, Tang A, Lee JM (2019) Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update. Clin Mol Hepatol. https://doi.org/10.3350/cmh.2018.0090

4. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK (2018) Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 68 (2):723-750

5. Galle PR, Forner A, Llovet JM, Mazzaferro V, Piscaglia F, Raoul J-L, Schirmacher P, Vilgrain V (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. Journal of hepatology 69 (1):182-236

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Value of CT Delayed Phase Images Added to Gd-EOB-DTPA MRI for HCC Diagnosis in LR-3/4 Lesions;International Journal of General Medicine;2023-06

2. Gadoxetate disodium-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: late portal venous phase may improve identification of enhancing capsule;Abdominal Radiology;2022-12-09

3. Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort;Current Oncology;2022-01-27

4. Imaging Diagnosis of HCC: Future directions with special emphasis on hepatobiliary MRI and contrast-enhanced ultrasound;Clinical and Molecular Hepatology;2021-12-27

5. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agents;Abdominal Radiology;2021-04-15